Dutch scientists successfully edited damaging mutations in human mitochondrial DNA using a base editor, offering hope for rare genetic diseases.
The research, published in *Molecular Therapy Nucleic Acids*, used a DdCBE base editor to correct mutations in liver and skin cells related to mitochondrial diseases.
The team also tested delivering the base editors as mRNA within lipid nanoparticles, showing improved efficacy and reduced toxicity.